✦ LIBER ✦

Efficacy of Switching from Statin Monotherapy to Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High-Risk Patients Analyzed by Baseline LDL-C

✍ Scribed by Philippe Brudi; Maurizio Averna; Michael Farnier; Luc Missault; Helena Vaverkova; Margus Viigimaa; Qian Dong; Arvind Shah; William Taggart; Amy O. Johnson-Levonas

Book ID: 119287832
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 189 KB
Volume: 4
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2010.03.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MS391 EFFICACY OF SWITCHING FROM STATIN

MS391 EFFICACY OF SWITCHING FROM STATIN MONOTHERAPY TO EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH-RISK PATIENTS ANALYZED BY BASELINE LDL-C

✍ Brudi, P.; Averna, M.; Farnier, M.; Missault, L.; Vaverkova, H.; Viigimaa, L.M.; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Ezetimibe/Simvastatin 10/20 mg Versus Ro

Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High Risk Hypercholesterolemic Patients Stratified by Previous Statin Treatment Potency

✍ Michael Farnier; Margus Viigimaa; Helena Vaverkova; Maurizio Averna; Luc Missaul 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 45 KB

Efficacy of Ezetimibe/Simvastatin 10/20

Efficacy of Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High-Risk Patients With or Without Obesity

✍ Luc Missault; Maurizio Averna; Michel Farnier; Helena Vaverkova; Margus Viigimaa 📂 Article 📅 2011 🏛 Springer Healthcare Communications ⚖ 677 KB

P273 EZETIMIBE/SIMVASTATIN 10/20 mg VERS

P273 EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH RISK HYPERCHOLESTEROLEMIC PATIENTS STRATIFIED BY PRIOR STATIN TREATMENT POTENCY

✍ Viigimaa, M.; Vaverkova, H.; Farnier, M.; Averna, M.; Missault, L.; Dong, Q.; Sh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Lipid-altering efficacy of ezetimibe/sim

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN-CROSS study

✍ M. Farnier; M. Averna; L. Missault; H. Vaverkova; M. Viigimaa; R. Massaad; K. Va 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Lipid-Altering Efficacy of Ezetimibe/Sim

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy

✍ Helena Vaverkova; Michel Farnier; Maurizio Averna; Luc Missault; Margus Viigimaa 📂 Article 📅 2010 🏛 Hindawi Limited 🌐 English ⚖ 895 KB